Medikal Ketojenik Diyet
Özet
Ketojenik diyet tedavileri (KDT), dirençli epilepsi nöbetlerini kontrol altına almak amacıyla yaklaşık 100 yıldır uygulanan; klasik, modifiye Atkins, MCT ve düşük glisemik indeksli olmak üzere dört ana gruptan oluşan yüksek yağlı bir tedavi yöntemidir. İki yaş altı dahil her yaş grubunda etkili olan bu tedavi, ilaçların yetersiz kaldığı durumlarda nöbetlerin azaltılması ve bilişsel iyileşme sağlamak için disiplinli bir klinik süreçle yönetilir. Tedavi süreci; detaylı ön değerlendirme ve düzenli laboratuvar takibi gerektirir; gastrointestinal sorunlar, hiperlipidemi ve böbrek taşı gibi yan etkiler ise uygun destekleyici tedavilerle yönetilebilir.
Ketogenic dietary therapies (KDT) are high-fat, low-carbohydrate medical interventions used for over a century to manage intractable epilepsy, categorized into classical, modified Atkins, MCT, and low glycemic index treatments. Effective across all age groups, including infants, these therapies are indicated when antiepileptic drugs fail, aiming to control seizures and promote cognitive improvement through a structured clinical process. Implementation requires rigorous pre-assessment and ongoing monitoring to manage potential side effects such as gastrointestinal issues, hyperlipidemia, and kidney stones, often mitigated by supplemental therapy.
Referanslar
Thompson L, Fecske E, Salim M, et al. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia 2017;58:e36–e39.
2.Dressler A, Trimmel-Schwahofer P, Reithofer E, et al. The ketogenic diet in infants—Advantages of early use. Epilepsy Res 2015;116:53–58.
3.Kim JA, Yoon JR, Lee EJ, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 2016;57:51–58.
4.Lambrechts DA, Wielders LH, Aldenkamp AP, et al. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 2012;23:310–314.
5.Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014;83:1978–1985.
Schoeler NE, Wood S, Aldridge V, et al. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav 2014;37:77–81.
Cervenka MC, Henry BJ, Felton EA, et al. Establishing an Adult Epilepsy Diet Center: experience, efficacy and challenges. Epilepsy Behav 2016;58:61–68.
Kossoff EH, McGrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47:421–424.
Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005;65:1810–1812.
Kossoff EH, Turner Z, Cervenka MC, Barron BJ editors. Ketogenic Diet Therapies for Epilepsy and Other Conditions. 7.Baskı. New York: Demos Health; 2021.
Farasat S, Kossoff EH, Pillas DJ, et al. The importance of cognition in parental expectations prior to starting the ketogenic diet. Epilepsy Behav 2006;8:406–410.
Van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol 2016;20:798–809.
Bergqvist AG, Schall JI, Gallagher PR, et al. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 2005;46:1810–1819.
Van der Louw EJ, Desadien R, Vehmeijer FO, et al. Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy. Seizure 2015;32:75–77.
Zarnowska I, Luszczki JJ, Zarnowski T, et al. Pharmacodynamic and pharmacokinetic interactions between common antiepileptic drugs and acetone, the chief anticonvulsant ketone body elevated in the ketogenic diet in mice. Epilepsia 2009;50:1132–1140.
Kossoff EH, Pyzik PL, Rubenstein JE, et al. Combined ketogenic diet and vagus nerve stimulation: rational polytherapy? Epilepsia 2007;48:77–81.
Dahlin MG, Beck OM, Amark PE. Plasma levels of antiepileptic drugs in children on the ketogenic diet. Pediatr Neurol 2006;35:6–10.
Coppola G, Verrotti A, D’Aniello A, et al. Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet. Acta Neurol Scand 2010;122:303–307.
Heo G, Kim SH, Chang MJ. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy. J Clinc Pharm Ther 2017;42:758–764.
20.Lyczkowski DA, Pfeifer HH, Ghosh S, et al. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia 2005;46:1533–1538.
Spilioti M, Pavlou E, Gogou M, et al. Valproate effect on ketosis in children under ketogenic diet. Eur J Paediatr Neurol 2016;20:555–559.
Spilioti M, Pavlou E, Gogou M, et al. Valproate effect on ketosis in children under ketogenic diet. Eur J Paediatr Neurol 2016;20:555–559.
Coppola G, Epifanio G, Auricchio G, et al. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 2006;28:358–365.
Takeoka M, Riviello JJ, Pfeifer H, et al. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia 2002;43:1072–1075.
Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43:1168–1171.
Paul E, Conant KD, Dunne IE, et al. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res 2010;90:151–156.
McNally MA, Pyzik PL, Rubenstein JE, et al. Empiric use of oral potassium citrate reduces symptomatic kidney stone incidence with the ketogenic diet. Pediatrics 2009;124:e300–e304.
Kossoff EH, Pyzik PL, McGrogan JR, et al. Impact of early versus late anticonvulsant reduction after ketogenic diet initiation. Epilepsy Behav 2004;5:499–502.
Huttenlocher P. Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536–540.
Lebel D, Morin C, Laberge M, et al. The carbohydrate and caloriccontent of concomitant medications for children with epilepsy on the ketogenic diet. Can J Neurol Sci 2001;28:322–340.
Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs 2015;17:141–150.
Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 2007;48:66–71.
Christodoulides SS, Neal EG, Fitzsimmons G, et al. The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels. J Hum Nutr Diet 2012;25:16–26.
Arslan N, Kose E, Guzel O. The effect of ketogenic diet on serum selenium levels in patients with intractable epilepsy. Biol Trace Elem Res 2017;178:1–6.
Bergqvist AG, Chee CM, Lutchka L, et al. Selenium deficiency with cardiomyopathy: a complication of the ketogenic diet. Epilepsia 2003;44:618–620.
Bank IM, Shemie SD, Rosenblatt B, et al. Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol 2008;39:429–431.
Sirikonda NS, Patten WD, Phillips JR, et al. Ketogenic diet: rapid onset of selenium deficiency-induced cardiac decompensation. Pediatr Cardiol 2012;33:834–838.
Sampath A, Kossoff EH, Furth SL, et al. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007;22:375–378.
McNally MA, Pyzik PL, Rubenstein JE, et al. Empiric use of oral potassium citrate reduces symptomatic kidney stone incidence with the ketogenic diet. Pediatrics 2009;124:e300–e304.
Kang HC, Chung DE, Kim DW, et al. Early and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116–1123.
Coppola G, Epifanio G, Auricchio G, et al. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 2006;28:358–365.
Berry-Kravis E, Booth G, Sanchez AC, et al. Carnitine levels and the ketogenic diet. Epilepsia 2001;42:1445–1451.
Alberti MJ, Agustinho A, Argumedo L, et al. Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet. Arch Argent Pediatr 2016;114:56–63.
AAP Committee on Nutrition. Ketogenic diet. In Kleinman RE, Greer FR (Eds) Pediatric nutrition. 7th Ed. Itasca, IL: AAP Press; 2013:1147–1166.
Van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol 2016;20:798–809.
Selter JH, Turner Z, Doerrer SC, et al. Dietary and medication adjustments to improve seizure control in patients treated with the ketogenic diet. J Child Neurol 2015;30:53–57.
Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000;15:787–790.
Van Delft R, Lambrechts D, Verschuure P, et al. Blood betahydroxybutyrate correlates better with seizures reduction due to ketogenic diet than urine ketosis. Seizure 2010;19:36–39.
Buchhalter JR, D’Alfonso S, Connolly M, et al. The relationship between D-beta-hydroxybutyrate blood concentrations and seizure control in children treated with the ketogenic diet for medically intractable epilepsy. Epilepsia Open 2017;2:317–321.
Kwiterovich PO Jr, Vining EP, Pyzik P, et al. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003;290:912–920.
Benn A, Swan CHJ, Cooke WT, et al. Effect of intralumninal pH on the absorption of pteroylmonoglutamic acid. British Med 1971;1:148–150.
Berry-Kravis E, Booth G, Sanchez AC, et al. Carnitine levels and the ketogenic diet. Epilepsia 2001;42:1445–1451.,
Alberti MJ, Agustinho A, Argumedo L, et al. Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet. Arch Argent Pediatr 2016;114:56–63.
Bergqvist AGC, Schall JI, Stallings VA, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 2008;88:1678–1684.
Selter JH, Turner Z, Doerrer SC, et al. Dietary and medication adjustments to improve seizure control in patients treated with the ketogenic diet. J Child Neurol 2015;30:53–57.
Lin A, Turner Z, Doerrer SC, et al. Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes. Pediatr Neurol 2017;68:35–39.
Caraballo R, Vaccarezza M, Cers_osimo R, et al. Long-term followup of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure 2011;20:640–645.
Zamani GR, Mohammadi M, Ashrafi MR, et al. The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol Belg 2016;116:529–534.
Liu YM, Lowe H, Zak MM, et al. Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy? J Child Neurol 2013;28:479–483.
Nizamuddin J, Turner Z, Rubenstein JE, et al. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 2008;23:758–761.
Guzel O, Yılmaz U, Uysal U, et al. The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 2016;37:465–470.
Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006;48:978–981.
Sampath A, Kossoff EH, Furth SL, et al. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007;22:375–378.
Furth SL, Casey JC, Pyzik PL, et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatric Nephrol 2000;15:125–128.
Neal EG, Chaffe HM, Edwards N, et al. Growth of children on classical and medium chain triglyceride diets. Pediatrics 2008;122:e334– e340.
Spulber G, Spulber S, Hagenas L, et al. Growth dependence on insulin- like growth factor-1 during the ketogenic diet. Epilepsia 2009;50:297–303.
Kessler SK, Gallagher PR, Shellhaas RA, et al. Early EEG improvement after ketogenic diet initiation. Epilepsy Res 2011;94:94–101.
Hamdy RF, Turner Z, Pyzik PL, et al. Lack of influence of body mass index on the efficacy of the ketogenic diet. J Child Neurol 2007;22:1167–1171.
Vining EP, Pyzik P, McGrogan J, et al. Growth of children on the ketogenic diet. Dev Med Child Neurol 2002;44:796–802.
Williams S, Basualdo-Hammond C, Curtis R, et al. Growth retardation in children with epilepsy on the ketogenic diet: a retrospective chart review. J Am Diet Assoc 2002;102:405–407.
Peterson SJ, Tangney CC, Pimentel-Zablah EM, et al. Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. J Am Diet Assoc 2005;105:718–725.
Best TH, Franz DN, Gilbert DL, et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54:2328–2330.
Sharma S, Gulati S. The ketogenic diet and the QT interval. J Clin Neurosci 2012;18:181–182.
Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol 2001;16:682.
Stevens CE, Turner Z, Kossoff EH. Hepatic dysfunction as a complication of combined ketogenic diet and valproic acid. Pediatr Neurol 2016;54:82–84.
Ballaban-Gil K, Callahan C, O’Dell C, et al. Complications of the ketogenic diet. Epilepsia 1998;39:744–748.
Wheless JW. The Ketogenic Diet: an effective medical therapy with side effects. J Child Neurol 2001;16:633–635
Kossoff EH, Laux LC, Blackford R, et al. When do seizures improve with the ketogenic diet? Epilepsia 2008;49:329–333.
Taub KS, Kessler SK, Bergqvist AG. Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet. Epilepsia 2014;55:579–583.
Klepper J, Leiendecker B. GLUT1 deficiency syndrome – 2007 update. Dev Med Child Neurol 2007;49:707–716.
Leen WG, Taher M, Verbeek MM, et al. GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol 2014;261:589–599.
Veggiotti P, De Giorgis V. Dietary treatments and new therapeutic perspective in GLUT1 deficiency syndrome. Curr Treat Options Neurol 2014;16:291.
Hong AM, Turner Z, Hamdy RF, et al. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 2010;51:1403–1407.
Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia 2011;52:e185–e189.
Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82:665–670.
Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia 2007;48:187–190.
Worden LT, Turner Z, Pyzik PL, et al. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res 2011;95:232–236.
